HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$16.37
Day range
$16.01 - $16.37
Year range
$6.56 - $16.48
Market cap
2.13B USD
Avg Volume
1.88M
P/E ratio
49.00
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 73.47M | 8.41% |
Operating expense | 35.22M | -29.11% |
Net income | 31.55M | 119.87% |
Net profit margin | 42.95 | 102.88% |
Earnings per share | 0.23 | 130.00% |
EBITDA | 34.61M | 107.98% |
Effective tax rate | 1.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 351.51M | 0.94% |
Total assets | 527.53M | -3.97% |
Total liabilities | 161.76M | 0.25% |
Total equity | 365.77M | — |
Shares outstanding | 131.84M | — |
Price to book | 5.91 | — |
Return on assets | 14.44% | — |
Return on capital | 17.27% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 31.55M | 119.87% |
Cash from operations | 44.45M | 161.02% |
Cash from investing | -13.77M | -30.27% |
Cash from financing | -10.49M | -285.38% |
Net change in cash | 20.19M | 440.48% |
Free cash flow | 33.12M | 341.23% |
About
Founded
2012
Headquarters
Website
Employees
130
